1. Home
  2. VNDA vs RMM Comparison

VNDA vs RMM Comparison

Compare VNDA & RMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • RMM
  • Stock Information
  • Founded
  • VNDA N/A
  • RMM 2019
  • Country
  • VNDA United States
  • RMM United States
  • Employees
  • VNDA N/A
  • RMM N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • RMM Trusts Except Educational Religious and Charitable
  • Sector
  • VNDA Health Care
  • RMM Finance
  • Exchange
  • VNDA Nasdaq
  • RMM Nasdaq
  • Market Cap
  • VNDA 362.6M
  • RMM 302.6M
  • IPO Year
  • VNDA 2006
  • RMM N/A
  • Fundamental
  • Price
  • VNDA $6.11
  • RMM $15.20
  • Analyst Decision
  • VNDA Buy
  • RMM
  • Analyst Count
  • VNDA 1
  • RMM 0
  • Target Price
  • VNDA $11.00
  • RMM N/A
  • AVG Volume (30 Days)
  • VNDA 885.4K
  • RMM 66.5K
  • Earning Date
  • VNDA 07-29-2024
  • RMM 01-01-0001
  • Dividend Yield
  • VNDA N/A
  • RMM 7.33%
  • EPS Growth
  • VNDA N/A
  • RMM N/A
  • EPS
  • VNDA N/A
  • RMM 0.96
  • Revenue
  • VNDA $177,604,000.00
  • RMM N/A
  • Revenue This Year
  • VNDA $2.98
  • RMM N/A
  • Revenue Next Year
  • VNDA $19.49
  • RMM N/A
  • P/E Ratio
  • VNDA N/A
  • RMM $15.55
  • Revenue Growth
  • VNDA N/A
  • RMM N/A
  • 52 Week Low
  • VNDA $3.30
  • RMM $12.32
  • 52 Week High
  • VNDA $6.75
  • RMM $16.10
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 58.51
  • RMM 50.30
  • Support Level
  • VNDA $5.89
  • RMM $15.15
  • Resistance Level
  • VNDA $6.33
  • RMM $15.50
  • Average True Range (ATR)
  • VNDA 0.25
  • RMM 0.18
  • MACD
  • VNDA 0.05
  • RMM -0.03
  • Stochastic Oscillator
  • VNDA 81.67
  • RMM 12.37

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

About RMM RiverNorth Managed Duration Municipal Income Fund Inc.

RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.

Share on Social Networks: